Multinational firms urged to compensate returned goods

Published: 2012-03-09 06:58:00

Updated: 2012-03-09 06:58:00

Despite the price cuts in January, six multinational drug manufactures decided not to compensate any returned goods sold before March, it was learned by an emergency council of the Korean Pharmaceutical Wholesaler Association at a meeting at Daejeon on Mar. 6.

These firms are Invida Korea, JS ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK